Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...

A new study has found that a group of diabetes drugs called SGLT2 inhibitors may increase the risk of a rare but dangerous ...

Two years on from The Royal Gazette’s first report on a new wave of diabetes drugs with broader health benefits, the island’s ...

More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health ...

A mainstay diabetes medication reduced pain and stiffness and improved function in overweight people with knee osteoarthritis ...

AstraZeneca posted higher profit in the first quarter, driven by sales of its diabetes and cancer medicines. The British ...

Opioids, antidepressants, and some NSAIDs increase the risk of constipation. Find out which ones do and what helps bowel ...

Researchers at Thomas Jefferson University have found a new way to help. Their study showed that using two diabetes ...

In patients with T2D who had been hospitalized for poorly controlled blood glucose, SGLT2 inhibitors nearly doubled the risk for falls, and combined use with GLP-1 RAs nearly tripled the risk.

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

The ‘4S’ Pathway was designed to guide shifting needs in older adults with diabetes who are struggling with diabetes ...